Rezolute Says FDA Recommends Pre-BLA Meeting for Congenital Hyperinsulinism Treatment
Rezolute (RZLT) said Monday that the US Food and Drug Administration has recommended a meeting befor
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo